Get startedLog in
    Picture of Sigilon Therapeutics logo

    SGTX — Sigilon Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapMomentum Trap
    All News

    Brief: Sigilon Therapeutics Inc - Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard Transfer Of Listing From Nasdaq

    Picture of Sigilon Therapeutics logoSigilon Therapeutics
    21/12/2022 21:42
    Dec 21 (Reuters) - Sigilon Therapeutics Inc  SGTX.O :
    * SIGILON THERAPEUTICS INC - RECEIVED NOTICE OF DELISTING OR
FAILURE TO SATISFY A CONTINUED LISTING RULE OR STANDARD;
TRANSFER OF LISTING FROM NASDAQ
    * SIGILON THERAPEUTICS INC - ON DEC 20, 2022, CO RECEIVED
NOTICE
FROM NASDAQ TO DELIST ITS SECURITIES UNLESS CO TIMELY REQUESTS
HEARING BEFORE PANEL
    * SIGILON THERAPEUTICS INC-INTENDS TO TIMELY REQUEST HEARING
BEFORE PANEL, WHICH REQUEST WILL STAY FURTHER ANY ACTION BY
NASDAQ PENDING PANEL’S DECISION

Further company coverage:  SGTX.O 
 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Sigilon Therapeutics

    See all news